Download FREE Report Sample
Download Free sampleIntegrin Alpha 4 Market contains market size and forecasts of Integrin Alpha 4 in global, including the following market information:
Global Integrin Alpha 4 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Integrin Alpha 4 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Integrin Alpha 4 companies in 2021 (%)
The global Integrin Alpha 4 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
TE-5232 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Integrin Alpha 4 include Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, EA Pharma Co Ltd, Immunwork Inc, Morphic Therapeutic Inc and Protagonist Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Integrin Alpha 4 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Integrin Alpha 4 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, by Type, 2021 (%)
TE-5232
ATL-1102
Carotegrast
ET-3764
Others
Global Integrin Alpha 4 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, by Application, 2021 (%)
Acute Ischemic Stroke
Celiac Disease
Epilepsy
Melanoma
Multiple Sclerosis
Other
Global Integrin Alpha 4 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Integrin Alpha 4 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Integrin Alpha 4 revenues share in global market, 2021 (%)
Key companies Integrin Alpha 4 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Integrin Alpha 4 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc
Antisense Therapeutics Ltd
Biogen Inc
BioMAS Ltd
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Immunwork Inc
Morphic Therapeutic Inc
Protagonist Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Viriom Inc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy